|
64
|
234
|
5lf4E |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
70
|
243
|
5l6aF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
241
|
5l5xG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
195
|
5l6aJ |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
57
|
204
|
5m2bI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
68
|
211
|
5l61K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
70
|
242
|
5l65D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
66
|
240
|
5m2bC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
66
|
250
|
5l5uA |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
66
|
211
|
5l66K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
57
|
204
|
5lttI |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
67
|
250
|
5l67A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
65
|
200
|
5lezK |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
65
|
211
|
5l65K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
67
|
216
|
5lf7M |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
66
|
250
|
5lttA |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
58
|
226
|
5l5oH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
244
|
5l5xB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
54
|
196
|
5lf7J |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
70
|
243
|
5l68F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
71
|
244
|
5lttB |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
63
|
231
|
5l67E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
63
|
211
|
5l5iK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
63
|
241
|
5l62G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
70
|
244
|
5l5tB |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
59
|
222
|
5l55L |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
70
|
243
|
5l55F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
63
|
211
|
5l5hK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
69
|
243
|
5l5oF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
244
|
5l54B |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
64
|
241
|
5l5eG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
240
|
5l5dC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
69
|
242
|
5l5oD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
222
|
5l52L |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
69
|
243
|
5l5fF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
59
|
195
|
5l5qJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
58
|
204
|
5l5xI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
71
|
233
|
5l5bM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
70
|
233
|
5l5sM |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
58
|
226
|
5l5jH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
71
|
243
|
5l5sF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
70
|
240
|
5l55C |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
68
|
240
|
5l5qC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
62
|
211
|
5l5eK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
250
|
5l5fA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
61
|
222
|
5l5iL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
59
|
226
|
5l5eH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
250
|
5l5iA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
63
|
211
|
5l5bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
69
|
244
|
5l5qB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
